halobetasol propionate · Mayne Pharma · NDA 210566
Lexette
Earliest generic entry, as listed
30 May 2037
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 10857159.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 10857159 | — | 30 May 2037 |
| US 10857159 | product | 30 Nov 2036 |
| US 11020407 | product, use U-3143 | 30 Nov 2036 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210566 · 001 · RLD · discontinued | aerosol, foam, topical | 0.05% | 30 May 2037 |